During the past decade, MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 7 clinical trials were completed, i.e. on average, 11.5% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 7 clinical trials were completed. i.e. 21.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford" are "Stage IV Lung Cancer AJCC v8" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials), "Stage III Lung Cancer AJCC v8" (5 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials) and "Stage IVB Lung Cancer AJCC v8" (5 trials). Many other conditions were trialed in "MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford" in a lesser frequency.

Most popular intervention types in "MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford" are "Drug" (49 trials), "Other" (42 trials), "Biological" (30 trials), "Procedure" (28 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (23 trials), "Questionnaire Administration" (19 trials), "Computed Tomography" (18 trials), "Biospecimen Collection" (15 trials) and "Nivolumab" (14 trials). Other intervention names were less common.

The vast majority of trials in "MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford" are 53 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford". undefined are not yet recruiting, 26 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford, 0 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".